WO2008011028A1 - Stent crimping apparatus and method - Google Patents

Stent crimping apparatus and method Download PDF

Info

Publication number
WO2008011028A1
WO2008011028A1 PCT/US2007/016200 US2007016200W WO2008011028A1 WO 2008011028 A1 WO2008011028 A1 WO 2008011028A1 US 2007016200 W US2007016200 W US 2007016200W WO 2008011028 A1 WO2008011028 A1 WO 2008011028A1
Authority
WO
WIPO (PCT)
Prior art keywords
balloon
stent
crimping
pressure
given value
Prior art date
Application number
PCT/US2007/016200
Other languages
French (fr)
Inventor
Bin Huang
David C. Gale
Daniel Castro
Original Assignee
Abbott Cardiovascular Systems Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Cardiovascular Systems Inc. filed Critical Abbott Cardiovascular Systems Inc.
Publication of WO2008011028A1 publication Critical patent/WO2008011028A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/9522Means for mounting a stent or stent-graft onto or into a placement instrument
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/49764Method of mechanical manufacture with testing or indicating
    • Y10T29/49771Quantitative measuring or gauging
    • Y10T29/49776Pressure, force, or weight determining
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/49826Assembling or joining
    • Y10T29/49908Joining by deforming
    • Y10T29/49925Inward deformation of aperture or hollow body wall
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/49826Assembling or joining
    • Y10T29/49908Joining by deforming
    • Y10T29/49925Inward deformation of aperture or hollow body wall
    • Y10T29/49927Hollow body is axially joined cup or tube
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/53Means to assemble or disassemble
    • Y10T29/53987Tube, sleeve or ferrule
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/53Means to assemble or disassemble
    • Y10T29/53991Work gripper, anvil, or element

Definitions

  • This invention relates to an apparatus for crimping a stent and a method for crimping a stent.
  • a typical stent is a cylindrically shaped device, which holds open and sometimes expands a segment of a blood vessel or other anatomical lumen such as urinary tracts and bile ducts.
  • Stents are often used in the treatment of atherosclerotic stenosis in blood vessels.
  • Stepnosis refers to a narrowing or constriction of the diameter of a bodily passage or orifice. In such treatments, stents reinforce body vessels and prevent restenosis following angioplasty.
  • Restenosis refers to the reoccurrence of stenosis in a blood vessel or heart valve after it has been subjected to angioplasty or valvuloplasty.
  • a stent is typically composed of scaffolding that includes a pattern or network of interconnecting structural elements often referred to in the art as struts or bar arms.
  • the scaffolding can be formed from wires, tubes, or sheets of material rolled into a cylindrical shape.
  • the stent is mounted on a balloon connected to a catheter.
  • a typical conventional method of mounting the stent on the balloon is a two-step process. First, the stent is compressed or crimped onto the balloon. Second, the compressed or crimped stent is retained or secured on the balloon. The retained stent should have a sufficiently small diameter so that it can be transported through the narrow passages of blood vessels. The stent must be secured on the balloon during delivery until it is deployed at an implant or treatment site within a vessel in the body of a patient. The stent is then expanded by inflating the balloon.
  • Delivery refers to introducing and transporting the crimped stent through a bodily lumen to the treatment site in a vessel.
  • Delivery corresponds to the expanding of the crimped stent within the lumen at the treatment site. Delivery and deployment of a stent are accomplished by positioning the stent about one end of a catheter, inserting the end of the catheter through the skin into a bodily lumen, advancing the catheter in the bodily lumen to a desired treatment location, inflating the stent at the treatment location, and removing the catheter from the lumen by deflating the balloon.
  • the stent should be firmly secured to the balloon to avoid detachment of the stent before it is delivered and deployed in the lumen of the patient. Detachment of a stent from the balloon during delivery and deployment can result in medical complications. A lost stent can act as an embolus that can create a thrombosis and require surgical intervention. For this reason, a stent must be securely attached to the catheter. Stent retention is greatly enhanced by protrusion of the balloon into the interstitial spaces or gaps between stent struts.
  • a polymer stent requires wider struts than a metal stent to achieve the same mechanical strength.
  • a polymer stent has smaller spaces or gaps between adjacent struts, making it more difficult for a balloon to protrude into the spaces to enhance stent retention.
  • a polymer stent may have a similar T g as the balloon material so that there is a limitation on the use of high temperature to enhance balloon protrusion into stent gaps. When high temperature is used during a crimping process, the stent tends to return to its original dimension and lose its preferred mechanical properties.
  • the balloon may be inflated when the stent is crimped onto the balloon, allowing the balloon to extend into the gaps of the stent to enhance stent retention.
  • a method for crimping a stent onto a balloon includes inflating a balloon with a fluid such as a gas or a liquid, sliding a stent over the inflated balloon, crimping the stent onto the balloon, and controlling the pressure inside the balloon below a given value when the stent is being crimped onto the balloon.
  • a fluid such as a gas or a liquid
  • the step of controlling includes releasing the fluid inside the balloon when the pressure exceeds the given value so that the pressure inside the balloon does not exceed the given value.
  • the step of releasing includes using a pressure release valve to control the fluid inside the balloon below the given value.
  • the method includes placing the stent and balloon in a crimper before the stent is crimped onto the balloon.
  • the method includes soaking the balloon in a solvent to soften the balloon.
  • the solvent may be acetone.
  • a method for crimping a stent onto a balloon includes sliding a stent over a balloon, placing the stent and balloon in a stent crimper, inflating the balloon with a fluid such as a gas or a liquid, crimping the stent onto the balloon, and controlling the pressure inside the balloon below a given value when the stent is being crimped onto the balloon.
  • the method includes reducing the crimper's inner diameter to the outer diameter of the stent before inflating the balloon with the fluid.
  • the step of controlling includes releasing the fluid inside the balloon when the pressure exceeds the given value so that the pressure inside the balloon does not exceed the given value.
  • the step of releasing includes using a pressure release valve to control the fluid inside the balloon below the given value.
  • the method includes soaking the balloon in a solvent to soften the balloon.
  • the solvent may be acetone.
  • a stent crimping apparatus includes means for inflating a balloon with a fluid such as a gas or a liquid, means for crimping the stent onto the balloon, and means for controlling the pressure inside the balloon below a given value when the stent is being crimped onto the balloon.
  • Figure 1 shows a perspective view of a stent.
  • Figure 2 shows one apparatus for crimping a stent according to the present invention.
  • Figure 3 shows portions of a balloon extending into the gaps of a stent.
  • Figure 1 illustrates a stent 10 that includes a number of interconnecting structural elements or struts 11.
  • the stent may include portions of struts that are straight or relatively straight, an example being a straight portion designated by reference numeral 12.
  • the stent may also include portions of struts that are bent, such as the portions designated by reference numerals 13, 14, and 15.
  • the bent portions 13, 14, and 15 may bend further when the stent 10 is crimped radially inwardly.
  • the bent portions 13, 14, and 15 may bend less when the stent 10 is expanded radially outwardly.
  • a stent as fabricated, is uncrimped and may have an outside diameter that is typically from about 1 mm and to 'about 4 mm.
  • the structural elements deform allowing the stent to decrease in diameter. The deformation occurs primarily at the bending elements.
  • the balloon when mounted on a catheter, may have an outside diameter of between about 0.7 mm and 0.8 mm.
  • the outside diameter of a crimped stent may be approximately the same as the outside diameter of the balloon.
  • a stent of the present invention may be formed from a tube by laser cutting the pattern of structural elements in the tube.
  • the stent may also be formed by laser cutting a polymeric or metallic sheet, rolling the pattern into the shape of the cylindrical stent, and providing a longitudinal weld to form the stent.
  • Other methods of forming stents are well known and include chemically etching a polymeric or metallic sheet and rolling and then welding it to form the stent.
  • a polymeric or metallic wire may also be coiled to form the stent.
  • the stent may be formed by injection molding of a thermoplastic or reaction injection molding of a thermoset polymeric material. Filaments of the compounded polymer may be extruded or melt spun.
  • filaments can then be cut, formed into ring elements, welded closed, corrugated to form crowns, and then the crowns welded together by heat or solvent to form the stent.
  • hoops or rings may be cut from tubing stock, the tube elements stamped to form crowns, and the crowns connected by welding or laser fusion to form the stent.
  • a stent can be made from one or more suitable materials.
  • a stent may be made from a metallic material.
  • a stent may be made from a polymeric material.
  • a stent may include a biodegradable material, such as a biodegradable polymer or metal.
  • the biodegradable material may be a pure or substantially pure biodegradable polymer or metal.
  • the biodegradable material may be a mixture of at least two types of biodegradable polymers and metals.
  • PEO/PLA polyphosphazenes
  • biomolecules such as fibrin, fibrinogen, cellulose, starch, collagen, and hyaluronic acid
  • polyurethanes silicones
  • polyesters polyolefins, polyisobutylene and ethylene-alphaolefin copolymers
  • acrylic polymers and copolymers vinyl halide polymers and copolymers (such as polyvinyl chloride), polyvinyl ethers (such as polyvinyl methyl ether), polyvinylidene halides (such as polyvinylidene chloride), polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics (such as polystyrene), polyvinyl esters (such as polyvinyl acetate), acrylonitrile- styrene copolymers, ABS resins, polyamides (such as Nylon 66 and polycaprolactam), polycarbonates, polyoxymethylenes, polyimides, polyethers
  • polymers that may be especially well suited for use in fabricating embodiments of implantable medical devices disclosed herein include ethylene vinyl alcohol copolymer (commonly known by the generic name EVOH or by the trade name EVAL), poly(butyl methacrylate), poly(vinylidene fluoride-co- hexafluoropropene) (e.g., SOLEF 21508, available from Solvay Solexis PVDF, Thorofare, NJ), polyvinylidene fluoride (otherwise known as KYNAR, available from ATOFINA Chemicals, Philadelphia, PA), ethylene-vinyl acetate copolymers, poly(vinyl acetate), styrene-isobutylene-styrene triblock copolymers, and polyethylene glycol.
  • EVAL ethylene vinyl alcohol copolymer
  • poly(butyl methacrylate) poly(vinylidene fluoride-co- hexafluoropropene)
  • Figure 2 illustrates one apparatus 20 for crimping a stent 22 according to the present invention.
  • a stent is to compress the stent radially inward to reduce its diameter.
  • the apparatus 20 may include one or more crimping elements 24, a source 26 for pressurized fluid, and a pressure control device 28.
  • the crimping elements 24 can be used to crimp the stent 22.
  • the crimping elements 24 may be any of the known crimping devices that can move radially to crimp the stent 22. Such crimping elements (or device) are well known in the art and will not be described in detail here.
  • the pressurized fluid source 26 can be used to supply pressurized fluid, such as pressurized gas or liquid, to inflate a balloon 30, on which the stent 22 is mounted.
  • the balloon 28 may be part of a catheter (not shown).
  • the pressurized fluid source 26 may be any device that can supply pressurized fluid, such as a pump or an accumulator.
  • the pressurized fluid source 26 is a pump 26.
  • a valve 32 is provided that can shut off the pressurized fluid supplied by the pump 26 to the balloon 30.
  • the pressure control device 28 may be used to control the pressure inside the balloon 30.
  • the pressure control device 28 may keep the pressure inside of the balloon 30 below a predetermined value.
  • the pressure control device may be any suitable device for achieving this purpose.
  • the pressure control device 28 is a pressure relief valve 28.
  • the balloon 30 is first inflated using the pressurized fluid supplied by the pump 26 (or any other suitable pressurized fluid source). To soften the balloon 30, the balloon 30 maybe soaked in a solvent, such as acetone, for a predetermine period of time. After the stent 22 at a first diameter value has been slid on the inflated balloon 30, the stent 22 and balloon 30 are placed in the stent crimping apparatus 20. Next, the crimping elements 24 may radially compress the stent 22 to reduce the stent's diameter to a second diameter value while the balloon remains inflated.
  • a solvent such as acetone
  • the balloon pressure may be kept at or below a first pressure value by the pressure relief valve 28. If the pressure inside the balloon 30 is above the first pressure value, the pressure relief valve 28 opens to discharge the pressurized fluid inside the balloon until the pressure reaches or is below the first pressure value. After the diameter of the stent has been reduced to the second diameter value, the balloon pressure may be kept at the first pressure value for a first period of time. Then the pressure inside the balloon may be released for a second period of time. Next the balloon is inflated again to a second pressure value, and the stent is crimped again until its diameter reaches a third diameter value. The balloon pressure may be kept at the second pressure value for a third period of time. Then the pressure inside the balloon niay be released, and the stent and balloon may be removed from the stent crimping apparatus 20.
  • the stent 22 is first slid on the balloon 30 without the balloon 30 being inflated.
  • the balloon 30 may be soaked in a solvent, such as acetone, for a predetermine period of time.
  • the stent 22 and balloon 30 are placed in the stent crimping apparatus 20.
  • the stent 22 may be radially compressed from a first diameter value to a second diameter value while the balloon is not inflated.
  • the balloon may be inflated to a first pressure value for a first period of time.
  • the stent is crimped again until its diameter reaches a third diameter value.
  • the balloon pressure may be kept at the first pressure value for a second period of time. Then the pressure inside the balloon may be released, and the stent and balloon may be removed from the stent crimping apparatus 20.
  • Figure 3 shows that after the stent 22 has been crimped onto the balloon 30 using a method of the present invention, portions 34 of the balloon 30 extend into the gaps of the stent 22.
  • the outer diameter of a pre-crimp stent is 0.135 inches.
  • the balloon is inflated to 39 psi, and the stent is mounted on the balloon.
  • the stent and balloon are placed in a stent crimping apparatus, and the stent is crimped to 0.090 inches while the balloon pressure is kept at 39 psi.
  • the balloon pressure is kept at 39 psi for 20 seconds.
  • the balloon may be deflated for a period of time.
  • the crimper then reduces the outer diameter of the stent to 0.045 inches for 50 seconds without balloon pressure.
  • the balloon is inflated again for 20 seconds under 39 psi. Then the balloon pressure is reduced to zero for 20 seconds.
  • the stent and balloon are removed from the crimper.
  • the outer diameter of an uncrimped stent is 0.084 inches.
  • the uncrimped stent is placed in a crimper, and the crimper's inner diameter is reduced to 0.084 inches, which is the outer diameter of the uncrimped stent.
  • the balloon is inflated under 30 psi pressure for 20 seconds.
  • the crimper then reduces the outer diameter of the stent to 0.032 inches under 30 psi for five seconds and then for 45 seconds without balloon pressure.
  • the balloon is inflated again for 25 seconds under 30 psi. Then the balloon pressure is reduced to zero for 10 seconds.
  • the stent and balloon are removed from the crimper.

Abstract

A method for crimping a stent onto a balloon includes inflating a balloon with a fluid, sliding a stent over the inflated balloon, crimping the stent onto the balloon, and controlling the pressure inside the balloon below a given value when the stent is being crimped onto the balloon.

Description

STENT CRIMPING APPARATUS AND METHOD
FIELD OF THE INVENTION
This invention relates to an apparatus for crimping a stent and a method for crimping a stent.
BACKGROUND
A typical stent is a cylindrically shaped device, which holds open and sometimes expands a segment of a blood vessel or other anatomical lumen such as urinary tracts and bile ducts. Stents are often used in the treatment of atherosclerotic stenosis in blood vessels. "Stenosis" refers to a narrowing or constriction of the diameter of a bodily passage or orifice. In such treatments, stents reinforce body vessels and prevent restenosis following angioplasty. "Restenosis" refers to the reoccurrence of stenosis in a blood vessel or heart valve after it has been subjected to angioplasty or valvuloplasty.
A stent is typically composed of scaffolding that includes a pattern or network of interconnecting structural elements often referred to in the art as struts or bar arms. The scaffolding can be formed from wires, tubes, or sheets of material rolled into a cylindrical shape.
In the case of a balloon expandable stent, the stent is mounted on a balloon connected to a catheter. A typical conventional method of mounting the stent on the balloon is a two-step process. First, the stent is compressed or crimped onto the balloon. Second, the compressed or crimped stent is retained or secured on the balloon. The retained stent should have a sufficiently small diameter so that it can be transported through the narrow passages of blood vessels. The stent must be secured on the balloon during delivery until it is deployed at an implant or treatment site within a vessel in the body of a patient. The stent is then expanded by inflating the balloon. "Delivery" refers to introducing and transporting the crimped stent through a bodily lumen to the treatment site in a vessel. "Deployment" corresponds to the expanding of the crimped stent within the lumen at the treatment site. Delivery and deployment of a stent are accomplished by positioning the stent about one end of a catheter, inserting the end of the catheter through the skin into a bodily lumen, advancing the catheter in the bodily lumen to a desired treatment location, inflating the stent at the treatment location, and removing the catheter from the lumen by deflating the balloon.
The stent should be firmly secured to the balloon to avoid detachment of the stent before it is delivered and deployed in the lumen of the patient. Detachment of a stent from the balloon during delivery and deployment can result in medical complications. A lost stent can act as an embolus that can create a thrombosis and require surgical intervention. For this reason, a stent must be securely attached to the catheter. Stent retention is greatly enhanced by protrusion of the balloon into the interstitial spaces or gaps between stent struts.
Stent retention for a polymer stent is especially challenging. Because polymers generally have lower strength than metals, a polymer stent requires wider struts than a metal stent to achieve the same mechanical strength. As a result, a polymer stent has smaller spaces or gaps between adjacent struts, making it more difficult for a balloon to protrude into the spaces to enhance stent retention. Additionally, a polymer stent may have a similar Tg as the balloon material so that there is a limitation on the use of high temperature to enhance balloon protrusion into stent gaps. When high temperature is used during a crimping process, the stent tends to return to its original dimension and lose its preferred mechanical properties.
SUMMARY
The present invention overcomes the above disadvantage of the prior art. In an preferred embodiment of the present invention, the balloon may be inflated when the stent is crimped onto the balloon, allowing the balloon to extend into the gaps of the stent to enhance stent retention.
In accordance with one aspect of the invention, a method for crimping a stent onto a balloon includes inflating a balloon with a fluid such as a gas or a liquid, sliding a stent over the inflated balloon, crimping the stent onto the balloon, and controlling the pressure inside the balloon below a given value when the stent is being crimped onto the balloon.
In a preferred embodiment of the invention, the step of controlling includes releasing the fluid inside the balloon when the pressure exceeds the given value so that the pressure inside the balloon does not exceed the given value.
In another preferred embodiment of the invention, the step of releasing includes using a pressure release valve to control the fluid inside the balloon below the given value.
In still another preferred embodiment of the invention, the method includes placing the stent and balloon in a crimper before the stent is crimped onto the balloon.
In a further embodiment of the invention, the method includes soaking the balloon in a solvent to soften the balloon. - The solvent may be acetone. In accordance with another aspect of the invention, a method for crimping a stent onto a balloon includes sliding a stent over a balloon, placing the stent and balloon in a stent crimper, inflating the balloon with a fluid such as a gas or a liquid, crimping the stent onto the balloon, and controlling the pressure inside the balloon below a given value when the stent is being crimped onto the balloon.
In a preferred embodiment of the invention, the method includes reducing the crimper's inner diameter to the outer diameter of the stent before inflating the balloon with the fluid.
In another preferred embodiment of the invention, the step of controlling includes releasing the fluid inside the balloon when the pressure exceeds the given value so that the pressure inside the balloon does not exceed the given value.
In still another preferred embodiment of the invention, the step of releasing includes using a pressure release valve to control the fluid inside the balloon below the given value.
In a further embodiment of the invention, the method includes soaking the balloon in a solvent to soften the balloon. The solvent may be acetone.
In accordance with a further aspect of the invention, a stent crimping apparatus includes means for inflating a balloon with a fluid such as a gas or a liquid, means for crimping the stent onto the balloon, and means for controlling the pressure inside the balloon below a given value when the stent is being crimped onto the balloon.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 shows a perspective view of a stent. Figure 2 shows one apparatus for crimping a stent according to the present invention.
Figure 3 shows portions of a balloon extending into the gaps of a stent.
DETAILED DESCRIPTION OF THE INVENTION
Those of ordinary skill in the art will realize that the following description of the invention is illustrative only and not in any way limiting. Other embodiments of the invention will readily suggest themselves to such skilled persons based on the disclosure herein. All such embodiments are within the scope of this invention.
Figure 1 illustrates a stent 10 that includes a number of interconnecting structural elements or struts 11. In general, the pattern of the stent struts is designed so that the stent can be radially compressed and expanded. The stent may include portions of struts that are straight or relatively straight, an example being a straight portion designated by reference numeral 12. The stent may also include portions of struts that are bent, such as the portions designated by reference numerals 13, 14, and 15. The bent portions 13, 14, and 15 may bend further when the stent 10 is crimped radially inwardly. The bent portions 13, 14, and 15 may bend less when the stent 10 is expanded radially outwardly.
A stent, as fabricated, is uncrimped and may have an outside diameter that is typically from about 1 mm and to 'about 4 mm. When the stent is crimped, the structural elements deform allowing the stent to decrease in diameter. The deformation occurs primarily at the bending elements. The balloon, when mounted on a catheter, may have an outside diameter of between about 0.7 mm and 0.8 mm. The outside diameter of a crimped stent may be approximately the same as the outside diameter of the balloon. In some embodiments, a stent of the present invention may be formed from a tube by laser cutting the pattern of structural elements in the tube. The stent may also be formed by laser cutting a polymeric or metallic sheet, rolling the pattern into the shape of the cylindrical stent, and providing a longitudinal weld to form the stent. Other methods of forming stents are well known and include chemically etching a polymeric or metallic sheet and rolling and then welding it to form the stent. A polymeric or metallic wire may also be coiled to form the stent. The stent may be formed by injection molding of a thermoplastic or reaction injection molding of a thermoset polymeric material. Filaments of the compounded polymer may be extruded or melt spun. These filaments can then be cut, formed into ring elements, welded closed, corrugated to form crowns, and then the crowns welded together by heat or solvent to form the stent. Lastly, hoops or rings may be cut from tubing stock, the tube elements stamped to form crowns, and the crowns connected by welding or laser fusion to form the stent.
A stent can be made from one or more suitable materials. For example, a stent may be made from a metallic material. Alternatively, a stent may be made from a polymeric material. A stent may include a biodegradable material, such as a biodegradable polymer or metal. The biodegradable material may be a pure or substantially pure biodegradable polymer or metal. Alternatively, the biodegradable material may be a mixture of at least two types of biodegradable polymers and metals.
Representative examples of polymers that may be used to fabricate embodiments of stents, or more generally, implantable medical devices include, but are not limited to, poly(N-acetylglucosamine) (Chitin), Chitosan, poly(3-hydroxyvalerate), poly(lactide-co- glycolide), poly(3-hydroxybutyrate), poly(4-hydroxybutyrate), poly(3-hydroxybutyrate- co-3-hydroxyvalerate), polyorthoester, polyanhydride, poly(glycolic acid), poly(glycolide), poly(L-lactic acid), poly(L-lactide), poly(D,L-lactic acid), poly(D,L- lactide), poly(L-lactide-co-D,L-lactide), poly(caprolactone), poly(L-lactide-co- caprolactone), poly(D,L-lactide-co-caprolactone), poly(glycolide-co-caprolactone), poly(trimethylene carbonate), polyester amide, poly(glycolic acid-co-trimethylene carbonate), co-poly(ether-esters) (e.g. PEO/PLA), polyphosphazenes, biomolecules (such as fibrin, fibrinogen, cellulose, starch, collagen, and hyaluronic acid), polyurethanes, silicones, polyesters, polyolefins, polyisobutylene and ethylene-alphaolefin copolymers, acrylic polymers and copolymers, vinyl halide polymers and copolymers (such as polyvinyl chloride), polyvinyl ethers (such as polyvinyl methyl ether), polyvinylidene halides (such as polyvinylidene chloride), polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics (such as polystyrene), polyvinyl esters (such as polyvinyl acetate), acrylonitrile- styrene copolymers, ABS resins, polyamides (such as Nylon 66 and polycaprolactam), polycarbonates, polyoxymethylenes, polyimides, polyethers, polyurethanes, rayon, rayon- triacetate, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, and carboxymethyl cellulose.
Additional representative examples of polymers that may be especially well suited for use in fabricating embodiments of implantable medical devices disclosed herein include ethylene vinyl alcohol copolymer (commonly known by the generic name EVOH or by the trade name EVAL), poly(butyl methacrylate), poly(vinylidene fluoride-co- hexafluoropropene) (e.g., SOLEF 21508, available from Solvay Solexis PVDF, Thorofare, NJ), polyvinylidene fluoride (otherwise known as KYNAR, available from ATOFINA Chemicals, Philadelphia, PA), ethylene-vinyl acetate copolymers, poly(vinyl acetate), styrene-isobutylene-styrene triblock copolymers, and polyethylene glycol. Figure 2 illustrates one apparatus 20 for crimping a stent 22 according to the present invention. In the present invention, to "crimp" a stent is to compress the stent radially inward to reduce its diameter. The apparatus 20 may include one or more crimping elements 24, a source 26 for pressurized fluid, and a pressure control device 28.
The crimping elements 24 can be used to crimp the stent 22. The crimping elements 24 may be any of the known crimping devices that can move radially to crimp the stent 22. Such crimping elements (or device) are well known in the art and will not be described in detail here.
The pressurized fluid source 26 can be used to supply pressurized fluid, such as pressurized gas or liquid, to inflate a balloon 30, on which the stent 22 is mounted. The balloon 28 may be part of a catheter (not shown). The pressurized fluid source 26 may be any device that can supply pressurized fluid, such as a pump or an accumulator. In the illustrated embodiment, the pressurized fluid source 26 is a pump 26. Preferably, a valve 32 is provided that can shut off the pressurized fluid supplied by the pump 26 to the balloon 30.
The pressure control device 28 may be used to control the pressure inside the balloon 30. For example, the pressure control device 28 may keep the pressure inside of the balloon 30 below a predetermined value. The pressure control device may be any suitable device for achieving this purpose. In the illustrated embodiment, the pressure control device 28 is a pressure relief valve 28.
To crimp the stent 22 on the balloon 30 in accordance with one method of the present invention, the balloon 30 is first inflated using the pressurized fluid supplied by the pump 26 (or any other suitable pressurized fluid source). To soften the balloon 30, the balloon 30 maybe soaked in a solvent, such as acetone, for a predetermine period of time. After the stent 22 at a first diameter value has been slid on the inflated balloon 30, the stent 22 and balloon 30 are placed in the stent crimping apparatus 20. Next, the crimping elements 24 may radially compress the stent 22 to reduce the stent's diameter to a second diameter value while the balloon remains inflated. During crimping, the balloon pressure may be kept at or below a first pressure value by the pressure relief valve 28. If the pressure inside the balloon 30 is above the first pressure value, the pressure relief valve 28 opens to discharge the pressurized fluid inside the balloon until the pressure reaches or is below the first pressure value. After the diameter of the stent has been reduced to the second diameter value, the balloon pressure may be kept at the first pressure value for a first period of time. Then the pressure inside the balloon may be released for a second period of time. Next the balloon is inflated again to a second pressure value, and the stent is crimped again until its diameter reaches a third diameter value. The balloon pressure may be kept at the second pressure value for a third period of time. Then the pressure inside the balloon niay be released, and the stent and balloon may be removed from the stent crimping apparatus 20.
To crimp the stent 22 on the balloon 30 in accordance with another method of the present invention, the stent 22 is first slid on the balloon 30 without the balloon 30 being inflated. To soften the balloon 30, the balloon 30 may be soaked in a solvent, such as acetone, for a predetermine period of time. Then the stent 22 and balloon 30 are placed in the stent crimping apparatus 20. Next the stent 22 may be radially compressed from a first diameter value to a second diameter value while the balloon is not inflated. After the diameter of the stent has been reduced to the second diameter value, the balloon may be inflated to a first pressure value for a first period of time. Then the stent is crimped again until its diameter reaches a third diameter value. The balloon pressure may be kept at the first pressure value for a second period of time. Then the pressure inside the balloon may be released, and the stent and balloon may be removed from the stent crimping apparatus 20.
Figure 3 shows that after the stent 22 has been crimped onto the balloon 30 using a method of the present invention, portions 34 of the balloon 30 extend into the gaps of the stent 22.
The following are two examples of stent crimping using a method of the present invention.
Example I
The outer diameter of a pre-crimp stent is 0.135 inches. The balloon is inflated to 39 psi, and the stent is mounted on the balloon. The stent and balloon are placed in a stent crimping apparatus, and the stent is crimped to 0.090 inches while the balloon pressure is kept at 39 psi. Next, the balloon pressure is kept at 39 psi for 20 seconds. Afterwards, the balloon may be deflated for a period of time. The crimper then reduces the outer diameter of the stent to 0.045 inches for 50 seconds without balloon pressure. The balloon is inflated again for 20 seconds under 39 psi. Then the balloon pressure is reduced to zero for 20 seconds. Finally, the stent and balloon are removed from the crimper.
Example π
The outer diameter of an uncrimped stent is 0.084 inches. The uncrimped stent is placed in a crimper, and the crimper's inner diameter is reduced to 0.084 inches, which is the outer diameter of the uncrimped stent. Next, the balloon is inflated under 30 psi pressure for 20 seconds. The crimper then reduces the outer diameter of the stent to 0.032 inches under 30 psi for five seconds and then for 45 seconds without balloon pressure. The balloon is inflated again for 25 seconds under 30 psi. Then the balloon pressure is reduced to zero for 10 seconds. Finally, the stent and balloon are removed from the crimper.
While particular embodiments of the present invention have been shown and described, it will be obvious to those skilled in the art that changes and modifications can be made without departing from this invention in its broader aspects.

Claims

What is claimed is:
1. A method for crimping a stent onto a balloon, comprising: inflating a balloon with a fluid; sliding a stent over, the inflated balloon; crimping the stent onto the balloon; and controlling the pressure inside the balloon below a given value when the stent is being crimped onto the balloon.
2. The method of claim 1, wherein the step of controlling includes releasing the fluid inside the balloon when the pressure exceeds the given value so that the pressure inside the balloon does not exceed the given value.
3. The method of claim 2, wherein the step of releasing includes using a pressure release valve to control the fluid inside the balloon below the given value.
4. The method of claim 1, further comprising placing the stent and balloon in a crimper before the stent is crimped onto the balloon.
5. The method of claim 1, further comprising soaking the balloon in a solvent to soften the balloon.
6. The method of claim 5, wherein the solvent is acetone.
7. A method for crimping a stent onto a balloon, comprising: sliding a stent over a balloon; placing the stent and balloon in a stent crimper; inflating the balloon with a fluid; crimping the stent onto the balloon; and controlling the pressure inside the balloon below a given value when the stent is being crimped onto the balloon.
8. The method of claim 7, further comprising reducing the crimper's inner diameter to the outer diameter of the stent before inflating the balloon with the fluid.
9. The method of claim 7, wherein the step of controlling includes releasing the fluid inside the balloon when the pressure exceeds the given value so that the pressure inside the balloon does not exceed the given value.
10. The method of claim 9, wherein the step of releasing includes using a pressure release valve to control the fluid inside the balloon below the given value.
11. The method of claim 1 , further comprising soaking the balloon in a solvent to soften the balloon.
12. The method of claim 11, wherein the solvent is acetone.
13. A stent crimping apparatus, comprising: means for inflating a balloon with a fluid; means for crimping the stent onto the balloon; and means for controlling the pressure inside the balloon below a given value when the stent is being crimped onto the balloon.
14. A apparatus for crimping a stent onto a balloon, comprising: a pressurized fluid source; a stent crimper; and a pressure regulator for keeping the pressure inside the balloon below a given value when the stent is being crimped onto the balloon by the stent crimper.
PCT/US2007/016200 2006-07-18 2007-07-17 Stent crimping apparatus and method WO2008011028A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/489,309 US7886419B2 (en) 2006-07-18 2006-07-18 Stent crimping apparatus and method
US11/489,309 2006-07-18

Publications (1)

Publication Number Publication Date
WO2008011028A1 true WO2008011028A1 (en) 2008-01-24

Family

ID=38626751

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/016200 WO2008011028A1 (en) 2006-07-18 2007-07-17 Stent crimping apparatus and method

Country Status (2)

Country Link
US (1) US7886419B2 (en)
WO (1) WO2008011028A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014055233A1 (en) * 2012-10-04 2014-04-10 Abbott Cardiovascular Systems Inc. Method of uniform crimping and expansion of medical devices
WO2014064183A1 (en) * 2012-10-25 2014-05-01 Arterial Remodeling Technologies, Sa Crimping method for bioresorbable stents
EP3184085A1 (en) * 2010-08-23 2017-06-28 Abbott Cardiovascular Systems Inc. Reducing crimping damage to polymer scaffold
US10555825B2 (en) 2017-11-09 2020-02-11 Abbott Cardiovascular Systems Inc. Rotation of a medical device during crimping
US10660773B2 (en) 2017-02-14 2020-05-26 Abbott Cardiovascular Systems Inc. Crimping methods for thin-walled scaffolds
US10967556B2 (en) 2018-06-11 2021-04-06 Abbott Cardiovascular Systems Inc. Uniform expansion of thin-walled scaffolds

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8597716B2 (en) 2009-06-23 2013-12-03 Abbott Cardiovascular Systems Inc. Methods to increase fracture resistance of a drug-eluting medical device
US9586030B2 (en) * 2004-12-23 2017-03-07 Boston Scientific Scimed, Inc. Fugitive plasticizer balloon surface treatment for enhanced stent securement
US8062465B1 (en) 2006-08-02 2011-11-22 Abbott Cardiovascular Systems Inc. Methods for improved stent retention
US8046897B2 (en) 2007-09-28 2011-11-01 Abbott Cardiovascular Systems Inc. Method and apparatus for stent retention on a balloon catheter
US9138338B2 (en) 2009-05-26 2015-09-22 Cook Medical Technologies Llc Two-stage method of compressing a stent
US8844113B2 (en) 2010-04-30 2014-09-30 Abbott Cardiovascular Systems, Inc. Methods for crimping a polymeric stent scaffold onto a delivery balloon
US8261423B2 (en) 2010-04-30 2012-09-11 Abbott Cardiovascular Systems Inc. Methods for crimping a polymeric stent onto a delivery balloon
US8752261B2 (en) * 2010-07-07 2014-06-17 Abbott Cardiovascular Systems Inc. Mounting stents on stent delivery systems
US8595913B2 (en) 2010-09-30 2013-12-03 Advanced Cardiovascular Systems, Inc. Stent crimping methods
US8961848B2 (en) 2011-04-18 2015-02-24 Abbott Cardiovascular Systems Inc. Methods for increasing a retention force between a polymeric scaffold and a delivery balloon
US9199408B2 (en) 2012-04-03 2015-12-01 Abbott Cardiovascular Systems Inc. Uniform crimping and deployment methods for polymer scaffold
US20120290063A1 (en) 2011-05-09 2012-11-15 Abbott Cardiovascular Systems Inc. Method of Increasing Stent Retention of Bioabsorbable Scaffolding with a Sheath
US8752265B2 (en) 2011-05-13 2014-06-17 Abbott Cardiovascular Systems Inc. Methods for crimping a polymeric scaffold to a delivery balloon and achieving stable mechanical properties in the scaffold after crimping
US8414528B2 (en) 2011-05-27 2013-04-09 Abbott Cardiovascular Systems Inc. Polymer scaffold sheaths
US8726483B2 (en) 2011-07-29 2014-05-20 Abbott Cardiovascular Systems Inc. Methods for uniform crimping and deployment of a polymer scaffold
US9440317B2 (en) 2013-01-07 2016-09-13 Abbott Cardiovascular Systems Inc. Post-crimping inspection of scaffolds mounted on scaffold delivery systems
JP6294564B2 (en) 2014-12-08 2018-03-14 サンテック・カンパニー・リミテッドSuntech Co.,Ltd. Biodegradable stent and shape memory expansion method thereof
JP2020162778A (en) * 2019-03-28 2020-10-08 テルモ株式会社 Method for manufacturing stent delivery system

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999015106A1 (en) * 1997-09-22 1999-04-01 Ave Connaught Balloon mounted stent and method therefor
WO2002030487A2 (en) * 2000-10-11 2002-04-18 Micro Thereapeutics, Inc. Methods for treating aneurysms
US20040078953A1 (en) * 2002-10-29 2004-04-29 Spilka David G Stent compression method

Family Cites Families (312)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1237035A (en) 1969-08-20 1971-06-30 Tsi Travmatologii I Ortopedii Magnesium-base alloy for use in bone surgery
US3900632A (en) 1970-02-27 1975-08-19 Kimberly Clark Co Laminate of tissue and random laid continuous filament web
US3839743A (en) 1972-04-21 1974-10-08 A Schwarcz Method for maintaining the normal integrity of blood
US4104410A (en) 1973-12-21 1978-08-01 Malecki George J Processing of green vegetables for color retention in canning
US4110497A (en) 1976-07-02 1978-08-29 Snyder Manufacturing Co., Ltd. Striped laminate and method and apparatus for making same
JPS6037735B2 (en) * 1978-10-18 1985-08-28 住友電気工業株式会社 Artificial blood vessel
DE2928007A1 (en) 1979-07-11 1981-01-15 Riess Guido Dr BONE IMPLANT BODY FOR PROSTHESES AND BONE CONNECTORS AND METHOD FOR THE PRODUCTION THEREOF
US4346028A (en) 1979-12-14 1982-08-24 Monsanto Company Asbestiform crystalline calcium sodium or lithium phosphate, preparation and compositions
DE3019996A1 (en) 1980-05-24 1981-12-03 Institute für Textil- und Faserforschung Stuttgart, 7410 Reutlingen HOHLORGAN
US4902289A (en) * 1982-04-19 1990-02-20 Massachusetts Institute Of Technology Multilayer bioreplaceable blood vessel prosthesis
US4517687A (en) 1982-09-15 1985-05-21 Meadox Medicals, Inc. Synthetic woven double-velour graft
US4656083A (en) * 1983-08-01 1987-04-07 Washington Research Foundation Plasma gas discharge treatment for improving the biocompatibility of biomaterials
US4594407A (en) 1983-09-20 1986-06-10 Allied Corporation Prosthetic devices derived from krebs-cycle dicarboxylic acids and diols
US5197977A (en) * 1984-01-30 1993-03-30 Meadox Medicals, Inc. Drug delivery collagen-impregnated synthetic vascular graft
US4633873A (en) * 1984-04-26 1987-01-06 American Cyanamid Company Surgical repair mesh
US4596574A (en) 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
CH671337A5 (en) 1984-06-19 1989-08-31 Ceskoslovenska Akademie Ved
US4879135A (en) 1984-07-23 1989-11-07 University Of Medicine And Dentistry Of New Jersey Drug bonded prosthesis and process for producing same
IT1186142B (en) * 1984-12-05 1987-11-18 Medinvent Sa TRANSLUMINAL IMPLANTATION DEVICE
US4718907A (en) * 1985-06-20 1988-01-12 Atrium Medical Corporation Vascular prosthesis having fluorinated coating with varying F/C ratio
US4818559A (en) * 1985-08-08 1989-04-04 Sumitomo Chemical Company, Limited Method for producing endosseous implants
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4743252A (en) 1986-01-13 1988-05-10 Corvita Corporation Composite grafts
EP0257091B1 (en) 1986-02-24 1993-07-28 Robert E. Fischell An intravascular stent and percutaneous insertion system
US4878906A (en) 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
EP0241838B1 (en) 1986-04-07 1992-04-15 Agency Of Industrial Science And Technology Antithrombogenic material
US4740207A (en) * 1986-09-10 1988-04-26 Kreamer Jeffry W Intralumenal graft
US4723549A (en) * 1986-09-18 1988-02-09 Wholey Mark H Method and apparatus for dilating blood vessels
US4722335A (en) * 1986-10-20 1988-02-02 Vilasi Joseph A Expandable endotracheal tube
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4816339A (en) * 1987-04-28 1989-03-28 Baxter International Inc. Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation
US5527337A (en) 1987-06-25 1996-06-18 Duke University Bioabsorbable stent and method of making the same
US5059211A (en) * 1987-06-25 1991-10-22 Duke University Absorbable vascular stent
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US4877030A (en) 1988-02-02 1989-10-31 Andreas Beck Device for the widening of blood vessels
US5192311A (en) * 1988-04-25 1993-03-09 Angeion Corporation Medical implant and method of making
US4994298A (en) * 1988-06-07 1991-02-19 Biogold Inc. Method of making a biocompatible prosthesis
US5502158A (en) 1988-08-08 1996-03-26 Ecopol, Llc Degradable polymer composition
US5328471A (en) 1990-02-26 1994-07-12 Endoluminal Therapeutics, Inc. Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens
US5019090A (en) 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
CA1322628C (en) 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
US5085629A (en) * 1988-10-06 1992-02-04 Medical Engineering Corporation Biodegradable stent
US4977901A (en) 1988-11-23 1990-12-18 Minnesota Mining And Manufacturing Company Article having non-crosslinked crystallized polymer coatings
CH678393A5 (en) 1989-01-26 1991-09-13 Ulrich Prof Dr Med Sigwart
DE69030811T2 (en) 1989-01-27 1997-10-02 Au Membrane & Biotech Res Inst RECEPTOR MEMBRANES AND SELECTIVE CONTROL OF THE ION FLOW BY IONOPHORES
US5163958A (en) 1989-02-02 1992-11-17 Cordis Corporation Carbon coated tubular endoprosthesis
US5289831A (en) * 1989-03-09 1994-03-01 Vance Products Incorporated Surface-treated stent, catheter, cannula, and the like
NZ228382A (en) 1989-03-17 1992-08-26 Carter Holt Harvey Plastic Pro Drug administering coil-like device for insertion in body cavity of animal
US5108755A (en) * 1989-04-27 1992-04-28 Sri International Biodegradable composites for internal medical use
US5100429A (en) * 1989-04-28 1992-03-31 C. R. Bard, Inc. Endovascular stent and delivery system
US4990158A (en) 1989-05-10 1991-02-05 United States Surgical Corporation Synthetic semiabsorbable tubular prosthesis
US5084065A (en) * 1989-07-10 1992-01-28 Corvita Corporation Reinforced graft assembly
US5147385A (en) 1989-11-01 1992-09-15 Schneider (Europe) A.G. Stent and catheter for the introduction of the stent
US5971954A (en) 1990-01-10 1999-10-26 Rochester Medical Corporation Method of making catheter
ATE120377T1 (en) 1990-02-08 1995-04-15 Howmedica INFLATABLE DILATATOR.
US5545208A (en) 1990-02-28 1996-08-13 Medtronic, Inc. Intralumenal drug eluting prosthesis
US5156623A (en) 1990-04-16 1992-10-20 Olympus Optical Co., Ltd. Sustained release material and method of manufacturing the same
US5123917A (en) 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5290271A (en) * 1990-05-14 1994-03-01 Jernberg Gary R Surgical implant and method for controlled release of chemotherapeutic agents
US5279594A (en) * 1990-05-23 1994-01-18 Jackson Richard R Intubation devices with local anesthetic effect for medical use
US5190540A (en) * 1990-06-08 1993-03-02 Cardiovascular & Interventional Research Consultants, Inc. Thermal balloon angioplasty
US6060451A (en) 1990-06-15 2000-05-09 The National Research Council Of Canada Thrombin inhibitors based on the amino acid sequence of hirudin
US5236447A (en) 1990-06-29 1993-08-17 Nissho Corporation Artificial tubular organ
US5342395A (en) 1990-07-06 1994-08-30 American Cyanamid Co. Absorbable surgical repair devices
US5112457A (en) 1990-07-23 1992-05-12 Case Western Reserve University Process for producing hydroxylated plasma-polymerized films and the use of the films for enhancing the compatiblity of biomedical implants
US5455040A (en) 1990-07-26 1995-10-03 Case Western Reserve University Anticoagulant plasma polymer-modified substrate
IL99296A (en) 1990-08-28 1995-12-08 Meadox Medicals Inc Self-supporting woven vascular graft and its preparation
DE69114505T2 (en) * 1990-08-28 1996-04-18 Meadox Medicals Inc SELF-SUPPORTING WOVEN VESSEL TRANSPLANT.
US5258020A (en) * 1990-09-14 1993-11-02 Michael Froix Method of using expandable polymeric stent with memory
US5163952A (en) 1990-09-14 1992-11-17 Michael Froix Expandable polymeric stent with memory and delivery apparatus and method
US5108417A (en) * 1990-09-14 1992-04-28 Interface Biomedical Laboratories Corp. Anti-turbulent, anti-thrombogenic intravascular stent
DE69116130T2 (en) 1990-10-18 1996-05-15 Ho Young Song SELF-EXPANDING, ENDOVASCULAR DILATATOR
US5104410A (en) * 1990-10-22 1992-04-14 Intermedics Orthopedics, Inc Surgical implant having multiple layers of sintered porous coating and method
US5163951A (en) 1990-12-27 1992-11-17 Corvita Corporation Mesh composite graft
CS277367B6 (en) 1990-12-29 1993-01-13 Krajicek Milan Three-layered vascular prosthesis
EP0525210A4 (en) * 1991-02-20 1993-07-28 Tdk Corporation Composite bio-implant and production method therefor
WO1992015342A1 (en) 1991-03-08 1992-09-17 Keiji Igaki Stent for vessel, structure of holding said stent, and device for mounting said stent
US5383925A (en) * 1992-09-14 1995-01-24 Meadox Medicals, Inc. Three-dimensional braided soft tissue prosthesis
US5356433A (en) 1991-08-13 1994-10-18 Cordis Corporation Biocompatible metal surfaces
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) * 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5500013A (en) 1991-10-04 1996-03-19 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5234457A (en) 1991-10-09 1993-08-10 Boston Scientific Corporation Impregnated stent
US5282860A (en) * 1991-10-16 1994-02-01 Olympus Optical Co., Ltd. Stent tube for medical use
US5545408A (en) 1991-10-21 1996-08-13 Peptide Technology Limited Biocompatible implant for the timing of ovulation in mares
US5167614A (en) 1991-10-29 1992-12-01 Medical Engineering Corporation Prostatic stent
US5756476A (en) 1992-01-14 1998-05-26 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of cell proliferation using antisense oligonucleotides
CA2087132A1 (en) * 1992-01-31 1993-08-01 Michael S. Williams Stent capable of attachment within a body lumen
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
DE69332950T2 (en) 1992-03-31 2004-05-13 Boston Scientific Corp., Natick BLOOD VESSEL FILTER
DE4222380A1 (en) 1992-07-08 1994-01-13 Ernst Peter Prof Dr M Strecker Endoprosthesis implantable percutaneously in a patient's body
US5306294A (en) * 1992-08-05 1994-04-26 Ultrasonic Sensing And Monitoring Systems, Inc. Stent construction of rolled configuration
US5514379A (en) 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
US5853408A (en) 1992-08-20 1998-12-29 Advanced Cardiovascular Systems, Inc. In-vivo modification of the mechanical properties of surgical devices
US5342621A (en) 1992-09-15 1994-08-30 Advanced Cardiovascular Systems, Inc. Antithrombogenic surface
US5830461A (en) 1992-11-25 1998-11-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods for promoting wound healing and treating transplant-associated vasculopathy
US5342348A (en) 1992-12-04 1994-08-30 Kaplan Aaron V Method and device for treating and enlarging body lumens
EP0604022A1 (en) 1992-12-22 1994-06-29 Advanced Cardiovascular Systems, Inc. Multilayered biodegradable stent and method for its manufacture
US5443458A (en) 1992-12-22 1995-08-22 Advanced Cardiovascular Systems, Inc. Multilayered biodegradable stent and method of manufacture
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
JP3583801B2 (en) 1993-03-03 2004-11-04 ボストン サイエンティフィック リミテッド Luminal stents and implants
FI92465C (en) * 1993-04-14 1994-11-25 Risto Tapani Lehtinen A method for handling endo-osteal materials
US5441515A (en) 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US5464650A (en) 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
US5437083A (en) * 1993-05-24 1995-08-01 Advanced Cardiovascular Systems, Inc. Stent-loading mechanism
US5994341A (en) * 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
EG20321A (en) 1993-07-21 1998-10-31 Otsuka Pharma Co Ltd Medical material and process for producing the same
DE69330132T2 (en) 1993-07-23 2001-11-15 Cook Inc FLEXIBLE STENT WITH A CONFIGURATION MOLDED FROM A MATERIAL SHEET
DK0716610T3 (en) 1993-08-26 2006-09-04 Genetics Inst Llc Human bone morphogenetic proteins for use in neural regeneration
DK0659389T3 (en) 1993-10-20 1999-02-15 Schneider Europ Ag endoprosthesis
US5723004A (en) 1993-10-21 1998-03-03 Corvita Corporation Expandable supportive endoluminal grafts
US5389106A (en) * 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
US5599301A (en) * 1993-11-22 1997-02-04 Advanced Cardiovascular Systems, Inc. Motor control system for an automatic catheter inflation system
SE501288C2 (en) 1993-11-30 1995-01-09 Corimed Gmbh Process for preparing ceramic implant material, preferably hydroxylapatite having ceramic implant material
US5626611A (en) 1994-02-10 1997-05-06 United States Surgical Corporation Composite bioabsorbable materials and surgical articles made therefrom
US5556413A (en) * 1994-03-11 1996-09-17 Advanced Cardiovascular Systems, Inc. Coiled stent with locking ends
US5599922A (en) * 1994-03-18 1997-02-04 Lynx Therapeutics, Inc. Oligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance properties
US5726297A (en) * 1994-03-18 1998-03-10 Lynx Therapeutics, Inc. Oligodeoxyribonucleotide N3' P5' phosphoramidates
AU704549B2 (en) 1994-03-18 1999-04-29 Lynx Therapeutics, Inc. Oligonucleotide N3'-P5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
US5399666A (en) * 1994-04-21 1995-03-21 E. I. Du Pont De Nemours And Company Easily degradable star-block copolymers
US5693085A (en) 1994-04-29 1997-12-02 Scimed Life Systems, Inc. Stent with collagen
US5629077A (en) 1994-06-27 1997-05-13 Advanced Cardiovascular Systems, Inc. Biodegradable mesh and film stent
US5670558A (en) 1994-07-07 1997-09-23 Terumo Kabushiki Kaisha Medical instruments that exhibit surface lubricity when wetted
US5554120A (en) 1994-07-25 1996-09-10 Advanced Cardiovascular Systems, Inc. Polymer blends for use in making medical devices including catheters and balloons for dilatation catheters
US5817327A (en) * 1994-07-27 1998-10-06 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
US6015429A (en) 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US5593403A (en) * 1994-09-14 1997-01-14 Scimed Life Systems Inc. Method for modifying a stent in an implanted site
US5578073A (en) 1994-09-16 1996-11-26 Ramot Of Tel Aviv University Thromboresistant surface treatment for biomaterials
US5649977A (en) 1994-09-22 1997-07-22 Advanced Cardiovascular Systems, Inc. Metal reinforced polymer stent
EP0785774B1 (en) * 1994-10-12 2001-01-31 Focal, Inc. Targeted delivery via biodegradable polymers
US5765682A (en) 1994-10-13 1998-06-16 Menlo Care, Inc. Restrictive package for expandable or shape memory medical devices and method of preventing premature change of same
US5836965A (en) 1994-10-19 1998-11-17 Jendersee; Brad Stent delivery and deployment method
IL115755A0 (en) 1994-10-27 1996-01-19 Medinol Ltd X-ray visible stent
US5836964A (en) 1996-10-30 1998-11-17 Medinol Ltd. Stent fabrication method
US5707385A (en) * 1994-11-16 1998-01-13 Advanced Cardiovascular Systems, Inc. Drug loaded elastic membrane and method for delivery
CA2301351C (en) 1994-11-28 2002-01-22 Advanced Cardiovascular Systems, Inc. Method and apparatus for direct laser cutting of metal stents
US5637113A (en) 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
US5919570A (en) 1995-02-01 1999-07-06 Schneider Inc. Slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a poly(N-vinylpyrrolidone) polymer hydrogel, coated polymer and metal substrate materials, and coated medical devices
US6017577A (en) 1995-02-01 2000-01-25 Schneider (Usa) Inc. Slippery, tenaciously adhering hydrophilic polyurethane hydrogel coatings, coated polymer substrate materials, and coated medical devices
US5876743A (en) * 1995-03-21 1999-03-02 Den-Mat Corporation Biocompatible adhesion in tissue repair
US5605696A (en) * 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US5837313A (en) 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US6120536A (en) 1995-04-19 2000-09-19 Schneider (Usa) Inc. Medical devices with long term non-thrombogenic coatings
JP2795824B2 (en) * 1995-05-12 1998-09-10 オオタ株式会社 Surface treatment method for titanium-based implant and biocompatible titanium-based implant
US5954744A (en) 1995-06-06 1999-09-21 Quanam Medical Corporation Intravascular stent
US5609629A (en) 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
CA2178541C (en) * 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US5591199A (en) 1995-06-07 1997-01-07 Porter; Christopher H. Curable fiber composite stent and delivery system
US5820917A (en) * 1995-06-07 1998-10-13 Medtronic, Inc. Blood-contacting medical device and method
US5667767A (en) 1995-07-27 1997-09-16 Micro Therapeutics, Inc. Compositions for use in embolizing blood vessels
GB9611437D0 (en) 1995-08-03 1996-08-07 Secr Defence Biomaterial
US5830879A (en) 1995-10-02 1998-11-03 St. Elizabeth's Medical Center Of Boston, Inc. Treatment of vascular injury using vascular endothelial growth factor
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5607442A (en) * 1995-11-13 1997-03-04 Isostent, Inc. Stent with improved radiopacity and appearance characteristics
US6579305B1 (en) 1995-12-07 2003-06-17 Medtronic Ave, Inc. Method and apparatus for delivery deployment and retrieval of a stent comprising shape-memory material
US6048964A (en) 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
DK2111876T3 (en) 1995-12-18 2011-12-12 Angiodevice Internat Gmbh Crosslinked polymer preparations and methods for their use
ATE290832T1 (en) 1996-01-05 2005-04-15 Medtronic Inc EXPANDABLE ENDOLUMINAL PROSTHESES
US6150630A (en) 1996-01-11 2000-11-21 The Regents Of The University Of California Laser machining of explosives
EP1011889B1 (en) 1996-01-30 2002-10-30 Medtronic, Inc. Articles for and methods of making stents
JP2000509014A (en) 1996-03-11 2000-07-18 フォーカル,インコーポレイテッド Polymer delivery of radionuclides and radiopharmaceuticals
US6071266A (en) 1996-04-26 2000-06-06 Kelley; Donald W. Lubricious medical devices
US6241760B1 (en) 1996-04-26 2001-06-05 G. David Jang Intravascular stent
US6592617B2 (en) 1996-04-30 2003-07-15 Boston Scientific Scimed, Inc. Three-dimensional braided covered stent
US5733326A (en) * 1996-05-28 1998-03-31 Cordis Corporation Composite material endoprosthesis
US5914182A (en) 1996-06-03 1999-06-22 Gore Hybrid Technologies, Inc. Materials and methods for the immobilization of bioactive species onto polymeric substrates
US5874165A (en) * 1996-06-03 1999-02-23 Gore Enterprise Holdings, Inc. Materials and method for the immobilization of bioactive species onto polymeric subtrates
US5830178A (en) 1996-10-11 1998-11-03 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide
US5800516A (en) 1996-08-08 1998-09-01 Cordis Corporation Deployable and retrievable shape memory stent/tube and method
US6344271B1 (en) 1998-11-06 2002-02-05 Nanoenergy Corporation Materials and products using nanostructured non-stoichiometric substances
US5855618A (en) * 1996-09-13 1999-01-05 Meadox Medicals, Inc. Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin
US5807404A (en) * 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US5913871A (en) 1996-09-25 1999-06-22 Medtronic, Inc. Balloon modification for improved stent fixation and deployment
US6387121B1 (en) 1996-10-21 2002-05-14 Inflow Dynamics Inc. Vascular and endoluminal stents with improved coatings
US5868781A (en) * 1996-10-22 1999-02-09 Scimed Life Systems, Inc. Locking stent
US5833651A (en) 1996-11-08 1998-11-10 Medtronic, Inc. Therapeutic intraluminal stents
US5877263A (en) * 1996-11-25 1999-03-02 Meadox Medicals, Inc. Process for preparing polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents
US5728751A (en) * 1996-11-25 1998-03-17 Meadox Medicals, Inc. Bonding bio-active materials to substrate surfaces
US5741881A (en) 1996-11-25 1998-04-21 Meadox Medicals, Inc. Process for preparing covalently bound-heparin containing polyurethane-peo-heparin coating compositions
IT1289728B1 (en) 1996-12-10 1998-10-16 Sorin Biomedica Cardio Spa SYSTEM AND EQUIPMENT DEVICE THAT INCLUDES IT
US5980972A (en) 1996-12-20 1999-11-09 Schneider (Usa) Inc Method of applying drug-release coatings
US5906759A (en) 1996-12-26 1999-05-25 Medinol Ltd. Stent forming apparatus with stent deforming blades
IT1291001B1 (en) 1997-01-09 1998-12-14 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT AND ITS PRODUCTION PROCESS
US5733330A (en) 1997-01-13 1998-03-31 Advanced Cardiovascular Systems, Inc. Balloon-expandable, crush-resistant locking stent
US6159951A (en) 1997-02-13 2000-12-12 Ribozyme Pharmaceuticals Inc. 2'-O-amino-containing nucleoside analogs and polynucleotides
US6582472B2 (en) 1997-02-26 2003-06-24 Applied Medical Resources Corporation Kinetic stent
US5971992A (en) * 1997-03-13 1999-10-26 Solar; Ronald J. Hydraulic method and apparatus for uniform radial compression and catheter mounting of radially expandable intraluminal stents and stented grafts
US6210715B1 (en) 1997-04-01 2001-04-03 Cap Biotechnology, Inc. Calcium phosphate microcarriers and microspheres
US5874101A (en) * 1997-04-14 1999-02-23 Usbiomaterials Corp. Bioactive-gel compositions and methods
US6240616B1 (en) 1997-04-15 2001-06-05 Advanced Cardiovascular Systems, Inc. Method of manufacturing a medicated porous metal prosthesis
US6273913B1 (en) 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
FI103715B (en) 1997-04-21 1999-08-31 Vivoxid Oy New composite and its use
US5879697A (en) * 1997-04-30 1999-03-09 Schneider Usa Inc Drug-releasing coatings for medical devices
US5741327A (en) 1997-05-06 1998-04-21 Global Therapeutics, Inc. Surgical stent featuring radiopaque markers
US6303901B1 (en) 1997-05-20 2001-10-16 The Regents Of The University Of California Method to reduce damage to backing plate
US5891192A (en) 1997-05-22 1999-04-06 The Regents Of The University Of California Ion-implanted protein-coated intralumenal implants
US6056993A (en) 1997-05-30 2000-05-02 Schneider (Usa) Inc. Porous protheses and methods for making the same wherein the protheses are formed by spraying water soluble and water insoluble fibers onto a rotating mandrel
DE19731021A1 (en) 1997-07-18 1999-01-21 Meyer Joerg In vivo degradable metallic implant
US5980928A (en) 1997-07-29 1999-11-09 Terry; Paul B. Implant for preventing conjunctivitis in cattle
US6340367B1 (en) 1997-08-01 2002-01-22 Boston Scientific Scimed, Inc. Radiopaque markers and methods of using the same
US6245103B1 (en) 1997-08-01 2001-06-12 Schneider (Usa) Inc Bioabsorbable self-expanding stent
US6174330B1 (en) 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US5980564A (en) 1997-08-01 1999-11-09 Schneider (Usa) Inc. Bioabsorbable implantable endoprosthesis with reservoir
US6121027A (en) 1997-08-15 2000-09-19 Surmodics, Inc. Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups
US6117979A (en) 1997-08-18 2000-09-12 Medtronic, Inc. Process for making a bioprosthetic device and implants produced therefrom
US6129928A (en) 1997-09-05 2000-10-10 Icet, Inc. Biomimetic calcium phosphate implant coatings and methods for making the same
US6284333B1 (en) 1997-09-10 2001-09-04 Scimed Life Systems, Inc. Medical devices made from polymer blends containing low melting temperature liquid crystal polymers
US6010445A (en) * 1997-09-11 2000-01-04 Implant Sciences Corporation Radioactive medical device and process
WO1999016871A2 (en) 1997-09-22 1999-04-08 Max-Planck-Gesellschaft Zur Forderung Der Wissensc Nucleic acid catalysts with endonuclease activity
DE69838256T2 (en) 1997-09-24 2008-05-15 Med Institute, Inc., West Lafayette RADIAL EXPANDABLE STENT
US5976182A (en) 1997-10-03 1999-11-02 Advanced Cardiovascular Systems, Inc. Balloon-expandable, crush-resistant locking stent and method of loading the same
US6769161B2 (en) * 1997-10-16 2004-08-03 Scimed Life Systems, Inc. Radial stent crimper
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
DE19881727D2 (en) 1997-11-24 2001-01-04 Herbert P Jennissen Process for immobilizing mediator molecules on inorganic and metallic implant materials
US6093463A (en) 1997-12-12 2000-07-25 Intella Interventional Systems, Inc. Medical devices made from improved polymer blends
US5957975A (en) 1997-12-15 1999-09-28 The Cleveland Clinic Foundation Stent having a programmed pattern of in vivo degradation
US6626939B1 (en) 1997-12-18 2003-09-30 Boston Scientific Scimed, Inc. Stent-graft with bioabsorbable structural support
US5986169A (en) 1997-12-31 1999-11-16 Biorthex Inc. Porous nickel-titanium alloy article
WO1999034750A1 (en) * 1998-01-06 1999-07-15 Bioamide, Inc. Bioabsorbable fibers and reinforced composites produced therefrom
US6224626B1 (en) 1998-02-17 2001-05-01 Md3, Inc. Ultra-thin expandable stent
RU2215542C2 (en) 1998-02-23 2003-11-10 Массачусетс Инститьют Оф Текнолоджи Biodecomposing polymers able recovery of form
DK1062278T3 (en) 1998-02-23 2006-09-25 Mnemoscience Gmbh Polymers with shape memory
US5938697A (en) 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6110188A (en) 1998-03-09 2000-08-29 Corvascular, Inc. Anastomosis method
US6063092A (en) * 1998-04-07 2000-05-16 Medtronic Inc. Heat set and crimping process to optimize stent retention
US6009614A (en) * 1998-04-21 2000-01-04 Advanced Cardiovascular Systems, Inc. Stent crimping tool and method of use
US6113629A (en) 1998-05-01 2000-09-05 Micrus Corporation Hydrogel for the therapeutic treatment of aneurysms
US6083258A (en) 1998-05-28 2000-07-04 Yadav; Jay S. Locking stent
DE19856983A1 (en) 1998-06-25 1999-12-30 Biotronik Mess & Therapieg Implantable, bioresorbable vascular wall support, in particular coronary stent
EP0966979B1 (en) 1998-06-25 2006-03-08 Biotronik AG Implantable bioresorbable support for the vascular walls, in particular coronary stent
US6153252A (en) 1998-06-30 2000-11-28 Ethicon, Inc. Process for coating stents
WO2000023123A1 (en) 1998-10-19 2000-04-27 Synthes Ag Chur Hardenable ceramic hydraulic cement
DE19855421C2 (en) * 1998-11-02 2001-09-20 Alcove Surfaces Gmbh Implant
DE69822470T2 (en) 1998-11-12 2005-01-20 Takiron Co. Ltd. Biodegradable absorbable shape memory material
US6125523A (en) 1998-11-20 2000-10-03 Advanced Cardiovascular Systems, Inc. Stent crimping tool and method of use
US6350277B1 (en) 1999-01-15 2002-02-26 Scimed Life Systems, Inc. Stents with temporary retaining bands
DE60017363T2 (en) 1999-02-02 2006-03-02 Wright Medical Technology Inc., Arlington CONTROLLED RELEASE OF A COMPOSITE MATERIAL
US6187045B1 (en) 1999-02-10 2001-02-13 Thomas K. Fehring Enhanced biocompatible implants and alloys
US6183505B1 (en) * 1999-03-11 2001-02-06 Medtronic Ave, Inc. Method of stent retention to a delivery catheter balloon-braided retainers
US6066156A (en) 1999-03-11 2000-05-23 Advanced Cardiovascular Systems, Inc. Temperature activated adhesive for releasably attaching stents to balloons
US6667049B2 (en) 1999-06-14 2003-12-23 Ethicon, Inc. Relic process for producing bioresorbable ceramic tissue scaffolds
US6312459B1 (en) 1999-06-30 2001-11-06 Advanced Cardiovascular Systems, Inc. Stent design for use in small vessels
US6177523B1 (en) * 1999-07-14 2001-01-23 Cardiotech International, Inc. Functionalized polyurethanes
AUPQ170799A0 (en) 1999-07-20 1999-08-12 Cardiac Crc Nominees Pty Limited Shape memory polyurethane or polyurethane-urea polymers
US6569193B1 (en) 1999-07-22 2003-05-27 Advanced Cardiovascular Systems, Inc. Tapered self-expanding stent
DE19938704C1 (en) * 1999-08-14 2001-10-31 Ivoclar Vivadent Ag Process for the production of reaction systems for implantation in the human and animal body as a bone substitute, which i.a. Contain calcium and phosphorus
US6479565B1 (en) 1999-08-16 2002-11-12 Harold R. Stanley Bioactive ceramic cement
US6379381B1 (en) 1999-09-03 2002-04-30 Advanced Cardiovascular Systems, Inc. Porous prosthesis and a method of depositing substances into the pores
JP4172883B2 (en) 1999-09-08 2008-10-29 Hoya株式会社 Drug sustained release carrier and method for producing drug sustained release carrier
WO2001026584A1 (en) 1999-10-14 2001-04-19 United Stenting, Inc. Stents with multilayered struts
DE19953771C1 (en) * 1999-11-09 2001-06-13 Coripharm Medizinprodukte Gmbh Absorbable bone implant material and method for producing the same
US7226475B2 (en) 1999-11-09 2007-06-05 Boston Scientific Scimed, Inc. Stent with variable properties
WO2001035928A1 (en) 1999-11-17 2001-05-25 Microchips, Inc. Microfabricated devices for the delivery of molecules into a carrier fluid
US7947069B2 (en) 1999-11-24 2011-05-24 University Of Washington Medical devices comprising small fiber biomaterials, and methods of use
US6554854B1 (en) 1999-12-10 2003-04-29 Scimed Life Systems, Inc. Process for laser joining dissimilar metals and endoluminal stent with radiopaque marker produced thereby
US6981987B2 (en) 1999-12-22 2006-01-03 Ethicon, Inc. Removable stent for body lumens
US6494908B1 (en) 1999-12-22 2002-12-17 Ethicon, Inc. Removable stent for body lumens
US6338739B1 (en) 1999-12-22 2002-01-15 Ethicon, Inc. Biodegradable stent
US6375826B1 (en) 2000-02-14 2002-04-23 Advanced Cardiovascular Systems, Inc. Electro-polishing fixture and electrolyte solution for polishing stents and method
KR100371559B1 (en) * 2000-04-03 2003-02-06 주식회사 경원메디칼 Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
US6527801B1 (en) * 2000-04-13 2003-03-04 Advanced Cardiovascular Systems, Inc. Biodegradable drug delivery material for stent
EP1153621A1 (en) 2000-05-12 2001-11-14 MERCK PATENT GmbH Biocements based on a mixture of TCP-PHA with improved compressive strength
US6395326B1 (en) 2000-05-31 2002-05-28 Advanced Cardiovascular Systems, Inc. Apparatus and method for depositing a coating onto a surface of a prosthesis
IL137090A (en) 2000-06-29 2010-04-15 Pentech Medical Devices Ltd Polymeric stent
US6569191B1 (en) 2000-07-27 2003-05-27 Bionx Implants, Inc. Self-expanding stent with enhanced radial expansion and shape memory
US6574851B1 (en) 2000-07-31 2003-06-10 Advanced Cardiovascular Systems, Inc. Stent made by rotational molding or centrifugal casting and method for making the same
US6485512B1 (en) 2000-09-27 2002-11-26 Advanced Cardiovascular Systems, Inc. Two-stage light curable stent and delivery system
US20020111590A1 (en) 2000-09-29 2002-08-15 Davila Luis A. Medical devices, drug coatings and methods for maintaining the drug coatings thereon
US6746773B2 (en) 2000-09-29 2004-06-08 Ethicon, Inc. Coatings for medical devices
US6492615B1 (en) 2000-10-12 2002-12-10 Scimed Life Systems, Inc. Laser polishing of medical devices
US6517888B1 (en) 2000-11-28 2003-02-11 Scimed Life Systems, Inc. Method for manufacturing a medical device having a coated portion by laser ablation
US6664335B2 (en) 2000-11-30 2003-12-16 Cardiac Pacemakers, Inc. Polyurethane elastomer article with “shape memory” and medical devices therefrom
US6565599B1 (en) 2000-12-28 2003-05-20 Advanced Cardiovascular Systems, Inc. Hybrid stent
US6540777B2 (en) 2001-02-15 2003-04-01 Scimed Life Systems, Inc. Locking stent
US6563080B2 (en) 2001-02-15 2003-05-13 Scimed Life Systems, Inc. Laser cutting of stents and other medical devices
US8262687B2 (en) 2001-02-27 2012-09-11 Kyoto Medical Planning Co., Ltd. Stent holding member and stent feeding system
US6764505B1 (en) 2001-04-12 2004-07-20 Advanced Cardiovascular Systems, Inc. Variable surface area stent
US6679980B1 (en) * 2001-06-13 2004-01-20 Advanced Cardiovascular Systems, Inc. Apparatus for electropolishing a stent
US6666880B1 (en) * 2001-06-19 2003-12-23 Advised Cardiovascular Systems, Inc. Method and system for securing a coated stent to a balloon catheter
US6695920B1 (en) * 2001-06-27 2004-02-24 Advanced Cardiovascular Systems, Inc. Mandrel for supporting a stent and a method of using the mandrel to coat a stent
US6585755B2 (en) 2001-06-29 2003-07-01 Advanced Cardiovascular Polymeric stent suitable for imaging by MRI and fluoroscopy
US7008446B1 (en) * 2001-08-17 2006-03-07 James Peter Amis Thermally pliable and carbon fiber stents
US6863683B2 (en) * 2001-09-19 2005-03-08 Abbott Laboratoris Vascular Entities Limited Cold-molding process for loading a stent onto a stent delivery system
JP2005503865A (en) 2001-09-28 2005-02-10 ボストン サイエンティフィック リミテッド Medical device comprising nanomaterial and treatment method using the same
US20030105530A1 (en) 2001-12-04 2003-06-05 Inion Ltd. Biodegradable implant and method for manufacturing one
US6752826B2 (en) 2001-12-14 2004-06-22 Thoratec Corporation Layered stent-graft and methods of making the same
US20030187495A1 (en) 2002-04-01 2003-10-02 Cully Edward H. Endoluminal devices, embolic filters, methods of manufacture and use
US7270675B2 (en) 2002-05-10 2007-09-18 Cordis Corporation Method of forming a tubular membrane on a structural frame
US20030236563A1 (en) 2002-06-20 2003-12-25 Dan Fifer Stent delivery catheter with retention bands
US7141063B2 (en) 2002-08-06 2006-11-28 Icon Medical Corp. Stent with micro-latching hinge joints
US6818063B1 (en) 2002-09-24 2004-11-16 Advanced Cardiovascular Systems, Inc. Stent mandrel fixture and method for minimizing coating defects
US7455687B2 (en) 2002-12-30 2008-11-25 Advanced Cardiovascular Systems, Inc. Polymer link hybrid stent
US20040143317A1 (en) 2003-01-17 2004-07-22 Stinson Jonathan S. Medical devices
US20040167610A1 (en) 2003-02-26 2004-08-26 Fleming James A. Locking stent
US6958073B2 (en) * 2003-04-21 2005-10-25 Medtronic Vascular, Inc. Method and system for stent retention using an adhesive
US6846323B2 (en) * 2003-05-15 2005-01-25 Advanced Cardiovascular Systems, Inc. Intravascular stent
US20060009832A1 (en) * 2004-07-09 2006-01-12 Conor Medsystems, Inc. Balloon catheter and method and system for securing a stent to a balloon catheter
US9283099B2 (en) * 2004-08-25 2016-03-15 Advanced Cardiovascular Systems, Inc. Stent-catheter assembly with a releasable connection for stent retention
US9000040B2 (en) * 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9586030B2 (en) * 2004-12-23 2017-03-07 Boston Scientific Scimed, Inc. Fugitive plasticizer balloon surface treatment for enhanced stent securement
US7563400B2 (en) * 2005-04-12 2009-07-21 Advanced Cardiovascular Systems, Inc. Method of stent mounting to form a balloon catheter having improved retention of a drug delivery stent
US7763198B2 (en) * 2005-04-12 2010-07-27 Abbott Cardiovascular Systems Inc. Method for retaining a vascular stent on a catheter
US7947207B2 (en) * 2005-04-12 2011-05-24 Abbott Cardiovascular Systems Inc. Method for retaining a vascular stent on a catheter
US7743481B2 (en) * 2005-04-29 2010-06-29 Arterial Remodelling Technologies, Inc. Stent crimping
US8099851B2 (en) * 2005-06-27 2012-01-24 Boston Scientific Scimed, Inc. Crimping and edge protection elements
US8956400B2 (en) * 2005-10-14 2015-02-17 Flexible Stenting Solutions, Inc. Helical stent
US8333000B2 (en) * 2006-06-19 2012-12-18 Advanced Cardiovascular Systems, Inc. Methods for improving stent retention on a balloon catheter
US8240020B2 (en) * 2006-06-30 2012-08-14 Advanced Cardiovascular Systems, Inc. Stent retention mold and method
US8046897B2 (en) * 2007-09-28 2011-11-01 Abbott Cardiovascular Systems Inc. Method and apparatus for stent retention on a balloon catheter
US8123793B2 (en) * 2008-09-10 2012-02-28 Boston Scientific Scimed, Inc. Pre-crimp balloon inflation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999015106A1 (en) * 1997-09-22 1999-04-01 Ave Connaught Balloon mounted stent and method therefor
WO2002030487A2 (en) * 2000-10-11 2002-04-18 Micro Thereapeutics, Inc. Methods for treating aneurysms
US20040078953A1 (en) * 2002-10-29 2004-04-29 Spilka David G Stent compression method

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3184085A1 (en) * 2010-08-23 2017-06-28 Abbott Cardiovascular Systems Inc. Reducing crimping damage to polymer scaffold
WO2014055233A1 (en) * 2012-10-04 2014-04-10 Abbott Cardiovascular Systems Inc. Method of uniform crimping and expansion of medical devices
JP2015533566A (en) * 2012-10-04 2015-11-26 アボット カルディオバスキュラー システムズ インコーポレーテッドAbbott Cardiovascular Systems Inc. Method for uniform crimping and expansion of medical devices
US9724219B2 (en) 2012-10-04 2017-08-08 Abbott Cardiovascular Systems Inc. Method of uniform crimping and expansion of medical devices
EP3360516A3 (en) * 2012-10-04 2018-08-29 Abbott Cardiovascular Systems Inc. Method of uniform crimping and expansion of medical devices
US10307277B2 (en) 2012-10-04 2019-06-04 Abbott Cardiovascular Systems Inc. Method of uniform crimping and expansion of medical devices
WO2014064183A1 (en) * 2012-10-25 2014-05-01 Arterial Remodeling Technologies, Sa Crimping method for bioresorbable stents
CN104884004A (en) * 2012-10-25 2015-09-02 动脉再造技术股份有限公司 Crimping method for bioresorbable stents
AU2013336675B2 (en) * 2012-10-25 2017-10-26 Sahajanand Medical Technologies Private Limited Crimping method for bioresorbable stents
US10660773B2 (en) 2017-02-14 2020-05-26 Abbott Cardiovascular Systems Inc. Crimping methods for thin-walled scaffolds
US10555825B2 (en) 2017-11-09 2020-02-11 Abbott Cardiovascular Systems Inc. Rotation of a medical device during crimping
US10967556B2 (en) 2018-06-11 2021-04-06 Abbott Cardiovascular Systems Inc. Uniform expansion of thin-walled scaffolds

Also Published As

Publication number Publication date
US7886419B2 (en) 2011-02-15
US20080016668A1 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
US7886419B2 (en) Stent crimping apparatus and method
US9504590B2 (en) Stent retained on a balloon catheter
US10342688B2 (en) Methods for improving stent retention on a balloon catheter
US20140081372A1 (en) Stent with retention protrusions formed during crimping
US9433517B2 (en) Stent having circumferentially deformable struts
US8099849B2 (en) Optimizing fracture toughness of polymeric stent
US8277498B2 (en) System for delivery of a stent at an elevated temperature
US8568469B1 (en) Stent locking element and a method of securing a stent on a delivery system
US20040215311A1 (en) Method and system for improving stent retention using stent openings

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07836099

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07836099

Country of ref document: EP

Kind code of ref document: A1